Litcius/Paper detail

759 THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY

David T. Rubin, Jessica R. Allegretti, Julián Panés, Nicole Shipitofsky, Shadi Yarandi, Kuan‐Hsiang Gary Huang, Matthew Germinaro, Rebbecca Wilson, Hongyan Zhang, Brian G. Feagan, Tadakazu Hisamatsu, Gary R. Lichtenstein, Brian Bressler, Laurent Peyrin‐Biroulet, Bruce E. Sands, Axel Dignaß

2024Gastroenterology14 citationsDOIOpen Access PDF

Topics & Concepts

Ulcerative colitisMedicineMaintenance therapyPhase (matter)Internal medicineChemotherapyDiseasePhysicsQuantum mechanicsInflammatory Bowel DiseaseMicroscopic ColitisEosinophilic Esophagitis
759 THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY | Litcius